BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 36672370)

  • 1. Feasibility of Using Wearables for Home Monitoring during Radiotherapy for Head and Neck Cancer-Results from the OncoWatch 1.0 Study.
    Holländer-Mieritz C; Steen-Olsen EB; Kristensen CA; Johansen C; Vogelius IR; Pappot H
    Cancers (Basel); 2023 Jan; 15(2):. PubMed ID: 36672370
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Using Biometric Sensor Data to Monitor Cancer Patients During Radiotherapy: Protocol for the OncoWatch Feasibility Study.
    Holländer-Mieritz C; Vogelius IR; Kristensen CA; Green A; Rindum JL; Pappot H
    JMIR Res Protoc; 2021 May; 10(5):e26096. PubMed ID: 33983123
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Monitoring Adolescent and Young Adult Patients With Cancer via a Smart T-Shirt: Prospective, Single-Cohort, Mixed Methods Feasibility Study (OncoSmartShirt Study).
    Steen-Olsen EB; Pappot H; Hjerming M; Hanghoej S; Holländer-Mieritz C
    JMIR Mhealth Uhealth; 2024 May; 12():e50620. PubMed ID: 38717366
    [TBL] [Abstract][Full Text] [Related]  

  • 4. App-Controlled Treatment Monitoring and Support for Head and Neck Cancer Patients (APCOT): Protocol for a Prospective Randomized Controlled Trial.
    Sprave T; Zöller D; Stoian R; Rühle A; Kalckreuth T; Haehl E; Fahrner H; Binder H; Grosu AL; Heinemann F; Nicolay NH
    JMIR Res Protoc; 2020 Dec; 9(12):e21693. PubMed ID: 33295291
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Feasibility of Using a Smartwatch to Intensively Monitor Patients With Chronic Obstructive Pulmonary Disease: Prospective Cohort Study.
    Wu R; Liaqat D; de Lara E; Son T; Rudzicz F; Alshaer H; Abed-Esfahani P; Gershon AS
    JMIR Mhealth Uhealth; 2018 Jun; 6(6):e10046. PubMed ID: 29903700
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A pilot study of a smartphone-based monitoring intervention on head and neck cancer patients undergoing concurrent chemo-radiotherapy.
    Zini EM; Lanzola G; Quaglini S; Bossi P; Licitra L; Resteghini C
    Int J Med Inform; 2019 Sep; 129():404-412. PubMed ID: 31445284
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preemptive treatment with Xonrid®, a medical device to reduce radiation induced dermatitis in head and neck cancer patients receiving curative treatment: a pilot study.
    Iacovelli NA; Naimo S; Bonfantini F; Cavallo A; Bossi P; Fallai C; Pignoli E; Alfieri S; Bergamini C; Favales F; Orlandi E
    Support Care Cancer; 2017 Jun; 25(6):1787-1795. PubMed ID: 28108819
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A monocentric, open-label randomized standard-of-care controlled study of XONRID®, a medical device for the prevention and treatment of radiation-induced dermatitis in breast and head and neck cancer patients.
    Ingargiola R; De Santis MC; Iacovelli NA; Facchinetti N; Cavallo A; Ivaldi E; Dispinzieri M; Franceschini M; Giandini C; Romanello DA; Di Biaso S; Sabetti M; Locati L; Alfieri S; Bossi P; Guglielmo M; Macchi F; Lozza L; Valdagni R; Fallai C; Pignoli E; Orlandi E
    Radiat Oncol; 2020 Aug; 15(1):193. PubMed ID: 32791985
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Self-management intervention for head and neck cancer couples: Results of a randomized pilot trial.
    Badr H; Herbert K; Chhabria K; Sandulache VC; Chiao EY; Wagner T
    Cancer; 2019 Apr; 125(7):1176-1184. PubMed ID: 30521075
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Feasibility of Monitoring Patients Who Have Cancer With a Smart T-shirt: Protocol for the OncoSmartShirt Study.
    Steen-Olsen EB; Pappot H; Green A; Langberg H; Holländer-Mieritz C
    JMIR Res Protoc; 2022 Oct; 11(10):e37626. PubMed ID: 36190744
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proton Beam Reirradiation for Recurrent Head and Neck Cancer: Multi-institutional Report on Feasibility and Early Outcomes.
    Romesser PB; Cahlon O; Scher ED; Hug EB; Sine K; DeSelm C; Fox JL; Mah D; Garg MK; Han-Chih Chang J; Lee NY
    Int J Radiat Oncol Biol Phys; 2016 May; 95(1):386-395. PubMed ID: 27084656
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pain management in patients undergoing radiation therapy for head and neck cancer - a descriptive study.
    Schaller AKCS; Peterson A; Bäckryd E
    Scand J Pain; 2021 Apr; 21(2):256-265. PubMed ID: 34387952
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Feasibility and preliminary effects of resistance training and nutritional supplements during versus after radiotherapy in patients with head and neck cancer: A pilot randomized trial.
    Sandmael JA; Bye A; Solheim TS; Stene GB; Thorsen L; Kaasa S; Lund JÅ; Oldervoll LM
    Cancer; 2017 Nov; 123(22):4440-4448. PubMed ID: 28759113
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pretreatment anemia is correlated with the reduced effectiveness of radiation and concurrent chemotherapy in advanced head and neck cancer.
    Prosnitz RG; Yao B; Farrell CL; Clough R; Brizel DM
    Int J Radiat Oncol Biol Phys; 2005 Mar; 61(4):1087-95. PubMed ID: 15752888
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Opioid therapy vs. multimodal analgesia in head and neck Cancer (OPTIMAL-HN): study protocol for a randomized clinical trial.
    Zayed S; Lang P; Mendez LC; Read N; Sathya J; Venkatesan V; Moulin DE; Warner A; Palma DA
    BMC Palliat Care; 2021 Mar; 20(1):45. PubMed ID: 33740977
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Radiation-induced hypothyroidism after treatment of head and neck cancer.
    Feen Rønjom M
    Dan Med J; 2016 Mar; 63(3):. PubMed ID: 26931197
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induction chemotherapy with docetaxel/cisplatin/5-fluorouracil followed by randomization to two cisplatin-based concomitant chemoradiotherapy schedules in patients with locally advanced head and neck cancer (CONDOR study) (Dutch Head and Neck Society 08-01): A randomized phase II study.
    Driessen CM; de Boer JP; Gelderblom H; Rasch CR; de Jong MA; Verbist BM; Melchers WJ; Tesselaar ME; van der Graaf WT; Kaanders JH; van Herpen CM
    Eur J Cancer; 2016 Jan; 52():77-84. PubMed ID: 26655558
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Radiation-induced cancer after radiotherapy for non-Hodgkin's lymphoma of the head and neck: a retrospective study.
    Toda K; Shibuya H; Hayashi K; Ayukawa F
    Radiat Oncol; 2009 Jul; 4():21. PubMed ID: 19591686
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Use of Wearables in Clinical Trials During Cancer Treatment: Systematic Review.
    Beauchamp UL; Pappot H; Holländer-Mieritz C
    JMIR Mhealth Uhealth; 2020 Nov; 8(11):e22006. PubMed ID: 33174852
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.